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Alcohol consumption in Australia costs the economy in excess of $14 billion per year with $1.686 billion attributed 
to healthcare costs1 and is responsible for 
4.6% of the disease burden.2 Chronic disease 
is the major contributor to disease burden 
in Australia and previous studies have 
demonstrated that alcohol consumption in 
people with chronic disease is similar to the 
general public.3 
The Australian safe drinking guidelines 
current at the time of this study suggest 
no more than two standard drinks per 
day to prevent chronic harm from alcohol 
consumption, with a standard drink being 
defined as containing 10g of alcohol.4 
However, 17% of Australians report exceeding 
this guideline in the preceding year.5 
General practitioners (GPs) are at the 
forefront of management of chronic disease 
and alcohol misuse,6 especially in regional 
settings where specialist services may be 
less available. Over half (53.3%) of all general 
practice encounters are attributable to 
management of chronic disease6; this equates 
to 76.2 million encounters per year. Similarly, 
general practice encounters for specified 
alcohol counseling exceed 500 000 per year,6 
ten-fold higher than alcohol consultations in 
specialist facilities.7 
Rates of alcohol consumption are higher 
than the national average in regional 
areas of Australia such as Townsville in 
north Queensland, where this study was 
undertaken;8 specialist alcohol and drug 
services are also limited in these areas. In 
addition, remoteness is associated with an 
excess of burden of disease in outer regional 
areas compared with major cities.2 This 
research follows from earlier work, which 
established that excess alcohol consumption 
was associated with lower attainment of 
chronic disease management targets and 
poorer chronic disease outcomes.9 The article 
addresses a gap in the existing literature by 
exploring the association between alcohol 
and the health system utilisation of chronic 
disease patients in a general practice setting 
in a regional centre. 
Methods
A retrospective chart audit of 12 months 
was undertaken by the primary author 
(also a registered medical practitioner) at 
two large, geographically separated multi-
doctor primary care practices in Townsville. 
Type 2 Diabetes Mellitus (T2DM),10 Chronic 
Obstructive Pulmonary Disease (COPD),11 
and Chronic Kidney Disease (CKD)12 were 
chosen as three indicator chronic diseases 
because they are common and have clear 
management guidelines for general practice. 
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Abstract
Objective: To understand the impact of alcohol consumption on the health utilisation of 
people with chronic diseases.
Methods: A retrospective chart audit was undertaken in two primary care settings in a regional 
Australian city. Three indicator conditions were selected: type 2 diabetes, chronic obstructive 
pulmonary disease and chronic kidney disease. The audits were analysed to examine the 
impact of alcohol consumption on primary care and hospital-based health utilisation.
Results: A total of 457 records were audited. Alcohol consumption decreased engagement in 
the primary care setting, with fewer visits, prescriptions and lower primary care costs. There 
was a U-shaped association between alcohol consumption and hospital attendance rates and 
costs. Admission rates were unchanged but a decrease in length of stay was observed in non-
smokers in the highest alcohol consumption category.
Conclusion: Excess alcohol consumption decreases engagement in primary care and results in 
increased emergency department attendance, but not admissions to hospital. In those who are 
admitted to hospital, alcohol is associated with a decreased length of stay.
Implications for public health: Alcohol consumption should be considered as a potential 
cause of decreased engagement in primary care. Follow-up and recall of patients may reduce 
shifting of care to the hospital environment. 
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To generate the patient list at each practice 
the electronic software was searched for 
records active (at least one visit) in the 
collection timeframe using the three indicator 
chronic diseases (T2DM, COPD and CKD) 
as diagnosis and keywords. No identifying 
details were collected. Patient lists were kept 
secured at the practice during collection 
and were destroyed at the completion of 
collection. 
All CKD records and every second T2DM 
and COPD record were extracted. Exclusion 
criteria were: no information regarding 
alcohol consumption; no evidence to support 
the presence of the chronic disease; evidence 
of the patient transferring into or out of the 
practice during the collection timeframe; 
no attendances recorded in the allotted 
timeframe; or on ethical grounds (patient 
was known to the researcher). Data points 
collected relevant to health utilisation are 
reported in Box 1, additional data collection 
on disease outcomes has been presented 
previously.9 
Ethics approval was obtained from James 
Cook University Human Research Ethics 
Committee [H6279]. Informed consent was 
obtained at the practice level.
Assessment of alcohol consumption
Alcohol consumption was assessed using 
the Alcohol Use Disorders Identification 
Tool-Consumption (AUDIT-C),13 which was 
embedded into the practice software and 
therefore the most consistent and reliable. For 
each patient the recorded AUDIT-C score was 
confirmed by utilising a keyword search to 
look for evidence of alcohol assessment in the 
written notes. 
In this study, the AUDIT-C was used as a proxy 
for consumption, with a high specificity cut-
off selected due to the retrospective nature 
of the study. The score was categorised as 
follows: score 0 (no consumption in last 12 
months), score 1–4 (low risk drinkers), score 
5–8 (moderate range drinkers) and score 
9+ (high risk drinkers). Patients identified as 
having a binge only pattern in the absence of 
any regular consumption (n=10) and patients 
with insufficient information to generate an 
AUDIT-C score (n=15) were excluded from the 
primary analysis. 
Classification of severity
COPD: assigned by spirometry FEV1% 
predicted or specialist determination if 
unable to do spirometry. 
•	 Mild: 60+% predicted; 
•	 Moderate: 41–59% predicted; 
•	 Severe: <40% predicted.
CKD: assigned by eGFR or formal GFR 
measurement where available. 
•	 Mild: eGFR > 60 + microalbuminuria or 
eGFR 45–59; 
•	 Moderate: eGFR 30–59+ microalbuminuria 
or eGFR 30-44 with no albuminuria; 
•	 Severe: eGFR <30 or macroalbuminuria. 
T2DM: severity was assigned by a 
combination of number of medications and 
HbA1c as described previously.9
Cost calculations for health system 
utilisation
Prescription costs were estimated using the 
average dispensed price for 2015–16: $45.00 
per script.14 Practice billings were collected 
from the practice software, to the nearest 
dollar, for each individual patient. Emergency 
Department and hospitalisation costs were 
derived from the Independent Hospital 
Pricing Authority15 and set at $660/ED 
presentation and $2,236/day for admissions. 
Analysis
Unless otherwise stated, statistical analyses 
were completed using SPSS 25.16 Differences 
between AUDIT-C groups in mean costs, 
prescription numbers and primary practice 
visits were compared using ANOVA if more 
than two groups, with Bonferroni post-hoc 
analysis where relevant. Where ANOVA 
homogeneity of variance conditions were 
not met, Welch tests with Games-Howell 
post-hoc analyses are reported. Where 
there were only two groups being analysed, 
independent samples t-tests were used. 
Data with small group sizes, outliers or that 
were not normally distributed were analysed 
using nonparametric tests (Kruskal-Wallis 
test for three groups or more, and Mann-
Whitney U test for two groups). Analysis of 
variance was performed for either single or 
groups of covariates that were independently 
associated with AUDIT-C score and the 
outcome measure, as specified in each result. 
Hospital admissions, emergency department 
attendance and hospital encounters (defined 
as an ED presentation and/or an admission) 
are presented as rate percentages (the 
number of people who experienced the 
encounter within the collection period as 
a percentage of the number of patients 
within the AUDIT-C category group). Groups 
were compared using relative risks with 
95% confidence intervals calculated using 
the online version of MedCalcTM software.17 
Comparisons of proportions were tested with 
Chi-squared test of independence or Fisher’s 
exact test where assumptions were violated. 
Where categorical variables were ordinal, chi-
square test for trend was used. 
Results
Data collection
The combined client base of the two large 
group practices was 19,704 or 11% of the 
total Townsville population; 63% (12,377) 
of these patients were seen during the 
collection period. From these records, 1,179 
patients were identified as having T2DM 
(n=644), COPD (n=385) or CKD (n=150), and 
482 of these records were audited. 
This resulted in 457 records after exclusions, 
as described in more detail elsewhere.9 
Briefly, mean age was 66 years (± 12years), 
and the sample was predominantly non-
Indigenous, non-smoking, and equally 
distributed between males and females. 
T2DM was the most frequent chronic disease 
(54%), followed by COPD (34%), and CKD 
12%). Only sex and current smoking status 
were significantly associated with AUDIT-C 
category.9 Table 1 shows health utilisation 
data by AUDIT-C scores of participants.
The impact of alcohol consumption 
on health care utilisation
Primary practice-based care
The care of people living with chronic disease 
within the primary practice environment was 
examined in terms of visits to the practice, 
prescription provision and practice billings. 
These were also used to derive a total primary 
care cost as outlined in the methods. 
Primary care encounters include visits to the 
doctor or nurse. The data contained some 
extreme outliers with six individuals having 
Box 1: Data points collected.
Diagnosis, age, gender, Indigenous identification, 
medications, number of doctor visits, number of nurse 
visits, Emergency Department (ED) presentations, hospital 
admissions, length of stay in hospital, alcohol use (frequency, 
amount, frequency of >6 drinks), glycated haemoglobin 
fraction (HbA1c; T2DM only), forced expiratory volume-
one second % predicted (FEV1 %; COPD only), estimated 
Glomerular Filtration Rate (eGFR; CKD only), gamma-
glutamyl transferase (GGT), alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), mean corpuscular volume 
(MCV), smoking status, and total practice billings for that 
patient.
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more than 60 visits per year, four of whom 
were in the AUDIT-C 0 category, one in the 
AUDIT-C 1–3 category and one in the AUDIT 
C 9+ category. These six individuals came 
from all three diagnostic groups, CKD (3), 
T2DM (2) and COPD (1). Therefore, practice 
visits were divided into categories (<4 
(quarterly), 5–12 (up to monthly), 13–26 (up 
to fortnightly), 27+ (more than fortnightly)) 
to limit the impact of outliers. An inverse 
association was observed between practice 
attendance and AUDIT-C score (X2=6.93; df=1; 
p=0.009, Table 1). Two per cent of patients 
who scored in the AUDIT-C 0 category had 
four or less annual practice visits compared 
with 9% of those scoring in the AUDIT-C 9+ 
category. Conversely, almost three-quarters 
(74%) of patients scoring in the AUDIT-C 0 
category had more than 13 practice visits, 
compared with approximately half (48%) 
those in the AUDIT-C 9+ category. A similar 
pattern was observed for prescription 
provision (F[3, 453]=3.22; p=0.023), though 
the only significant post-hoc differences 
were between AUDIT-C 0 and AUDIT-C 9+ 
categories (p=0.042). Analysis of variance 
models remained significant after adjustment 
for age (F[3, 455]=3.02; p=0.029). 
Total primary care costs (Table 1) declined 
with increasing AUDIT-C score category 
(F[3, 453]=4.06; p=0.007); mean costs were 
only significantly higher in the AUDIT-C 0 
than in AUDIT-C 9+ categories (p=0.013) in 
post-hoc analyses. The association between 
total primary care costs and AUDIT-C score 
remained significant after adjustment for age, 
gender, diagnosis, and current smoking status 
(F[3, 453]=3.31; p=0.020). The same pattern 
was observed for prescription costs (F[3, 
453]=3.33; p=0.020) with mean prescription 
costs also significantly higher in AUDIT-C 
0 than AUDIT-C 9+ categories (p=0.033) in 
post-hoc analyses. The association between 
PBS costs and AUDIT-C score remained 
significant after adjustment for age, gender, 
diagnosis, and current smoking status (F[3, 
453]=2.95;  p=0.033). While the same pattern 
was observed for practice billing, this was not 
significant (F[3, 453]=2.08; p=0.102). 
Hospital-based care
Overall, 35% (n=162) of participants used 
the hospital at least once in the year. Twenty 
per cent (n=93) visited the emergency 
department (without being admitted), 
and 22% were admitted to hospital at least 
once (Table 1). There were no significant 
gender differences in the proportion 
of admissions (both 21%), emergency 
department attendances (females 23%, 
males 16%; X2=3.46, df=1; p=0.063) or 
hospital attendance (females 36%, males 
33%; X2=0.44; df=1; p=0.507). There was no 
association between Indigenous status and 
emergency department attendance (X2=1.52, 
df=1; p=0.218) or overall hospital encounters 
(X2=3.02; df=1; p=0.082), but there was 
an increased frequency of admissions in 
Indigenous people (28%) compared with 
non-indigenous people (19%) (X2=4.85; df=1; 
p=0.03). There was no association between 
smoking and emergency department 
attendance (X2=1.19; df=1; p=0.275) or 
hospital encounters (X2=2.16; df=1; p=0.141), 
but a higher proportion of smokers were 
admitted (29%) than non-smokers (19%; 
X2=4.59; df=1; p=0.032). 
The association between AUDIT-C score 
and hospital use approximated an 
asymmetric U-shaped curve (Figure 1, 
panel A), a pattern also seen for emergency 
department attendance (Figure 1, panel 
B), and admissions (Figure 1, panel C). The 
highest attendances were observed in those 
who scored in the 0 category, lowest costs 
occurred in the 5–8 category, and costs 
increased again in the 9+ category. Rates 
for total hospital encounters, emergency 
department encounters, and admissions are 
presented in Table 1.
For each separate type of encounter, relative 
risks and 95%CI were calculated comparing 
each AUDIT category with every other AUDIT 
category. Only rates that were significantly 
different from each other are reported here. 
The relative risk was higher in the AUDIT-C 
9+ group than in the AUDIT-C 5–8 group for 
attending the emergency department (RR:2.6; 
95%CI: 1.1–6.0; p=0.03), having a hospital 
encounter (RR:1.8; 95%CI: 1.0–3.1; p=0.04), 
but not for admissions (RR:1.5; 95%CI: 0.7–3.3; 
p=0.32). 
To account for the impact of multiple 
attendances by individuals, mean costs in 
each group were compared. Total hospital 
costs (Figure 1, panel A), emergency 
department costs (Figure 1, panel B) and 
admission costs (Figure 1, panel C) follow the 
same approximate asymmetric U-shape as 
encounters. Emergency department costs 
differed significantly by AUDIT-C category 
(F [3,179]=4.10; p=0.008), with mean costs 
in patients in the AUDIT-C 5–8 category 
significantly lower than in the 1–4 category 
(p=0.036), and also lower than patients in the 
AUDIT-C 9+ category, though this difference 
was not significant (p=0.16) – most likely due 
to sample size. There were no differences in 
admission costs (F=1.69; df=3, 146; p=0.17) 
or total hospital costs (F=1.88; df=3,147; 
p=0.135) according to AUDIT-C score. 




0 1–4 5–8 9+
Number of records 198 158 58 43 457
Males, n (%) 77 (39%) 80 (51%) 40 (69%) 32 (74%) 229 (50%)
Current Non-Smoker, n (%) 157 (79%) 138 (87%) 40 (69%) 21 (49%) 356 (78%)
Severity Category, n (%)
 Mild 79 (40%) 70 (44%) 29 (50%) 20 (47%) 198 (43%)
 Moderate 78 (39%) 63 (40%) 23 (40%) 12 (28%) 176 (39%)
 Severe 41 (21%) 25 (16%) 6 (10%) 11 (25%) 83 (18%)
Number of Medications, mean (SEM) 6.9(0.3) 6.3(0.5) 6.0 (0.9) 5.3 (0.5) 6.4 (0.2)
Practice encounters, n (%) 
 ≤4 3 (2%) 1 (1%) 1 (2%) 4 (9%) 9 (2%)
 5–12 48 (25%) 43 (27%) 20 (33%) 20 (43%) 131 (29%)
 13–26 90 (47%) 76 (48%) 23 (37%) 13 (28%) 202 (44%)
 ≥27 51 (27%) 38 (24%) 17 (28%) 9 (20%) 115 (25%)
Practice Billings, $, mean (SEM) 1,144 (51) 1,029 (49) 992 (130) 915 (140) 1,062 (31)
Total Primary Care Costs, $, mean (SEM) 5,920 (222) 4,998 (192) 5,563 (242) 4,500 (686) 5,399 (123)
Number attended ED, n (%) 41 (24%) 33 (21%) 7 (12%) 12 (28%) 93 (20%)
ED costs $, mean (SEM) 295 (85) 221 (44) 76 (32) 215 (60) 227 (40)
Number admitted, n (%) 46 (23%) 34 (21%) 10 (18%) 10 (23%) 100 (22%)
Admission Costs, $, mean (SEM) 4,620 (1091) 2,062 (514) 1,743 (807) 2,558 (1551) 3,065 (525)
Number with hospital encounter, n (%) 72 (36%) 57 (36%) 15 (26%) 18 (42%) 162 (35%)
Total Hospital Costs, $ mean (SEM) 4,939 (1100) 2,283 (526) 1,819 (814) 2,773 (1565) 3,258 (526)
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As admission rates differed by Indigenous 
status and current smoking status (see 
hospital-based care above), analyses of 
the association between AUDIT-C and 
admission costs, total hospital costs and 
length of stay were then stratified by 
Indigenous status and smoking status. 
Adjusting for Indigenous status did not alter 
the findings described above, except for 
length of stay which reflected the smoking 
effect described below, most likely due to 
an overrepresentation of smokers in the 
Indigenous 9+ category. There was an effect 
from current smoking status. In non-smokers 
there was a significant association between 
AUDIT-C and emergency department costs 
(F=5.25; df=3,101; p=0.02), total hospital 
costs (F=2.92, df=3, 112; p=0.037), and an 
equivocal effect on admission costs (F=2.68, 
df=3, 114; p=0.05). For each of these costs, 
the asymmetric U-shape was approximated 
and the most pronounced decline in costs 
as evidenced through post-hoc analyses was 
observed from the AUDIT-C 1–4 category to 
the 5–8 category. In hospitalised patients, 
length of stay was also statistically different 
(F=2.77; df=3, 352; p=0.04) – length of stay 
was highest in AUDIT-C category 0 and lower 
in both the AUDIT-C 5-8 (p=0.042) and 9+ 
category (p=0.035, Figure 1, panel D). In 
smokers, there was no association between 
total hospital costs (F=0.16; df=3, 97; p=0.92), 
admission costs (F=0.15; df=3, 97; p=0.93) or 
length of stay (F=0.15; df=3, 97; p=0.93) and 
AUDIT-C category, potentially the result of a 
substantially lower sample size. 
Discussion
Overall, alcohol had a measurable impact on 
the health care utilisation of people living 
with chronic disease as measured through 
primary practice and hospital visits. 
Alcohol consumption patterns
AUDIT-C is verified as a screening tool for 
alcohol dependence but has been used 
previously as a proxy for consumption.13 As 
identified previously,9 AUDIT–C scores over 
five are consistent with drinking in excess 
of Australian safe drinking guidelines, with 
scores of four equivocal, suggesting 30% 
of the people with chronic disease in this 
study were drinking in excess of guidelines, 
compared with 17% of the general Australian 
population in 2015.5 Abstinence rates, at 40%, 
were also higher than the general population 
(19.4%5). 
Validity of the sample
The overall proportion of people with COPD 
and T2DM reflects the proportions in the 
Australian population.5 The proportion for 
CKD is substantially lower than anticipated 
by national rates, especially in the mild range. 
It is likely that many of the excluded CKD 
records, where insufficient evidence was 
available to support the diagnosis (47/150) 
were mild CKD with pre-existing evidence 
that was unavailable. 
As previously reported,9 the large total patient 
pool, geographically dispersed, increases the 
likelihood that the sample is representative 
of the Townsville population with chronic 
disease. Comparison of the demographics of 
the T2DM sample with a national diabetes 
audit sample of over 5,000 people showed 
similar demographics, blood pressure 
readings, lipid levels and HbA1c ranges.18 This 
provides some evidence for generalisability of 
the observed results to the wider Australian 
population living with chronic disease. 
However, the national diabetes audit did not 
report on alcohol consumption.18
Impact of alcohol consumption on 
health costs
Despite evidence of worsening disease 
outcomes with increased alcohol 
consumption, these results consistently 
demonstrate a trend towards decreased 
health care utilisation at higher levels of 
alcohol consumption. This was observed 
for general practice visits, prescription 
numbers, practice billings and total costs. The 
exception is costs from hospital attendances, 
for which there is an approximate U-shaped 
curve and increasing hospital encounters, 
ED visits and a trend towards increasing 
admissions (albeit non-significant), in the 
highest consumption category relative to 
moderate drinking. U-shaped or J-shaped 
associations in response to alcohol abound 
in the literature, and are frequently attributed 
to a protective effect of low levels of drinking.  
However, a 195-nation global burden of 
disease study by Griswald et al. (2018), the 
largest of its kind, demonstrated that the 
level of alcohol consumption that minimised 
harm was zero, with an uncertainty interval 
of 0-0.8 drinks per week.19 In the Griswald 
study, the apparent protective effect reported 
elsewhere is attributed to an artefact due 
to confounders in the zero consumption 
group.19 In the current study, it is likely that 
many former drinkers had ceased alcohol 
use due to their chronic health condition, 
increasing the variability seen in the zero 
consumption category. 
When the analyses were stratified by 
smoking, the association was significant for 
non-smokers. This suggests that people with 
Figure 1: The impact of AUDIT-C category on (A) Mean overall hospital use; (B) Mean emergency department 
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higher alcohol consumption are missing 
out on regular preventive care, thus having 
more acute presentations. As hospital costs 
per encounter are more expensive than 
primary care costs, this suggests that more 
active follow-up of disengaged patients and 
consideration of alcohol consumption as a 
potential contributing factor could potentially 
prevent hospital attendances. 
This phenomenon is seen elsewhere in the 
literature. Sacco et al.20 showed that while 
alcohol consumption did not increase overall 
health costs in patients with depression, it 
was associated with a different admission 
pattern. Patients were more likely to be 
admitted but had a shorter length of stay. 
Similarly, in the current study, there was no 
significant change to the number of annual 
presentations to hospital, but there was a 
decrease in length of stay in non-smokers 
consuming alcohol. The reasons for the 
observed reduced health care utilisation 
cannot be explained using the data available 
in this study, but are likely to be a complex 
interplay between the physiological impacts 
of chronic excess alcohol consumption on 
chronic disease progression, the behavioral 
implications of the potential impairment 
from alcohol consumption and stigma that 
may impair help seeking. Interestingly, 
the observed decrease in length of stay 
represents an average discharge in the 
AUDIT-C 9+ group of 32 hours, which 
approximates the onset of phase two alcohol 
withdrawal.21 This raises the possibility 
that early discharge in these patients 
could potentially be related to withdrawal 
syndromes, either as self-discharge due 
to unrecognised withdrawal or deliberate 
discharge before the onset of withdrawal. A 
large prospective cohort study of emergency 
department attendances and hospital 
admission relative to alcohol consumption 
would better elucidate the impact of alcohol 
consumption on hospitalisation patterns 
in people with chronic disease, and would 
also allow investigation into factors affecting 
repeat presentations. However, such a study 
would be contingent on adequate and 
detailed coding of alcohol consumption at 
presentation to hospital. 
Limitations
The limitations of the overarching study 
have been discussed previously,9 but include 
challenges associated with practice data 
that are designed for clinical management 
not research, and the inability to distinguish 
recent ex-drinkers from long-term ex-drinkers 
or those who have never drunk alcohol. Of 
most relevance to this paper is the fact that 
hospital attendance data are derived from 
the practice data and will potentially not 
reflect attendances where the patient has not 
specified the correct GP practice or where 
the hospital has failed to provide discharge 
summaries. This limitation was mitigated 
by the delayed retrospective access of 
practice data by the researcher, which gave 
time for discharge summaries to have been 
incorporated into the record. 
These limitations are offset by the benefits 
of using primary care data as recorded 
for usual care, clear inclusion criteria, 
consistency of collection and a sample size 
that exceeded the minimum 360 records 
suggested by sample size calculations. In 
addition, the sample is socioeconomically 
and demographically diverse and comparable 
to large national samples, which increases the 
generalisabiltiy of the findings. 
Conclusions
Increasing alcohol consumption, as recorded 
in practice records, was associated with a 
decreased utilisation of health services in 
people with chronic diseases. This consisted 
of a decreased use of primary care and 
medications, an increase in emergency 
department attendances, no change in 
admission rates and a decrease in length of 
stay in non-smokers. 
It is recommended that staff in primary 
care consider alcohol consumption when 
patients are disengaging with health services. 
Additionally, improved coding of alcohol 
use in hospitals would assist in determining 
the reasons for altered admission patterns in 
people consuming excess alcohol.
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